Page last updated: 2024-10-25

deferoxamine and Nephrosclerosis

deferoxamine has been researched along with Nephrosclerosis in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Nephrosclerosis: Hardening of the KIDNEY due to infiltration by fibrous connective tissue (FIBROSIS), usually caused by renovascular diseases or chronic HYPERTENSION. Nephrosclerosis leads to renal ISCHEMIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCarthy, JT1
Libertin, CR1
Mitchell, JC1
Fairbanks, VF1
Dittrich, P1
Huber, H1
Stühlinger, W1

Other Studies

2 other studies available for deferoxamine and Nephrosclerosis

ArticleYear
Hemosiderosis in a dialysis patient: treatment with hemofiltration and deferoxamine chelation therapy.
    Mayo Clinic proceedings, 1982, Volume: 57, Issue:7

    Topics: Aged; Blood; Deferoxamine; Drug Combinations; Female; Hemosiderosis; Humans; Nephrosclerosis; Renal

1982
[Studies on clearance of Fe59-tagged desferrioxamine in healthy kidney function and kidney diseases].
    Wiener klinische Wochenschrift, 1966, Jul-01, Volume: 78, Issue:26

    Topics: Aminohippuric Acids; Deferoxamine; Glomerulonephritis; Humans; Iron Isotopes; Kidney; Kidney Functio

1966